{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T18:02:32Z","timestamp":1771437752042,"version":"3.50.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:p>\n                    Gastric cancer (GC) remains a leading cause of cancer mortality, yet the causal roles of microRNAs (miRNAs) in its pathogenesis are poorly characterized. While observational studies implicate miRNAs in GC progression, confounding biases and tissue-specific limitations hinder causal inference and clinical translation. We conducted a 2-sample Mendelian randomization (MR) analysis using genetic instruments derived from plasma miRNA expression quantitative trait loci (eQTLs). Summary-level data for miRNA-eQTLs were obtained from a study by Huan et al. (involving 5239 individuals and 280 miRNAs), while genetic associations with GC were sourced from 3 independent genome-wide association studies (ebi-a-GCST90018849, ebi-a-GCST90018629, and bbj-a-119) accessed via the IEU OpenGWAS Project. Instrumental variables were constructed using miRNA-eQTLs that reached significance at a false discovery rate (FDR\u2005&lt;\u2005 0.1. Causal estimates were primarily generated using inverse-variance weighted regression, supplemented by MR-Egger regression to assess and adjust for potential pleiotropy. Sensitivity analyses, including leave-one-out validation, were performed to evaluate the robustness of the findings. Experimentally validated targets were analyzed for differential expression, prognostic relevance, and somatic mutations. Functional enrichment and pan-cancer analyses were conducted to delineate oncogenic mechanisms. MR analysis revealed 5 plasma miRNAs with consistent causal effects on GC risk: hsa-miR-127-3p, hsa-miR-370-3p, hsa-miR-382-5p, hsa-miR-409-3p, and hsa-miR-654-5p. All 5 miRNAs conferred increased risk (ORs 1.021\u20131.037, all \u2005\u22640.0025) across the 3 cohorts (ebi-a-GCST90018849, ebi-a-GCST90018629, bbj-a-119). These miRNAs collectively targeted 549 genes, of which 76 were differentially expressed in GC tissues. Seventeen dysregulated targets showed prognostic significance, with enrichment in immune regulation (T\/B cell receptor signaling) and cancer pathways. In GC, miR-409-3p overexpression independently predicted poor survival (H\u2005=\u2005 1.55,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .0098) and inversely correlated with multiple targets (XKR4, F2, ATAD5, GNAL, GDNF, UNC13A, and ELL2). Pan-cancer analysis revealed oncogenic roles for causal miRNAs in 16 malignancies, with miR-409-3p showing GC-specific prognostic significance. This MR study establishes plasma miRNAs as causal mediators of gastric carcinogenesis, with miR-409-3p emerging as a key prognostic biomarker. The identified miRNA-target networks highlight actionable pathways for therapeutic intervention, bridging genetic epidemiology with functional genomics in GC precision oncology.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046833","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:02:43Z","timestamp":1767711763000},"page":"e46833","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mendelian randomization identifies circulating miRNAs as causal mediators of gastric cancer susceptibility and survival outcomes"],"prefix":"10.1097","volume":"105","author":[{"given":"Yejue","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Surgery, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8207-444X","authenticated-orcid":false,"given":"Ming","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260218","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention.","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R2-20260218","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.4251\/wjgo.v16.i5.2123","article-title":"MiRNA-145-5p inhibits gastric cancer progression via the serpin family E member 1- extracellular signal-regulated kinase-1\/2 axis.","volume":"16","author":"Bai","year":"2024","journal-title":"World J Gastrointest Oncol"},{"key":"R3-20260218","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13062-024-00549-z","article-title":"MIR194-2HG, a miRNA host gene activated by HNF4A, inhibits gastric cancer by regulating microRNA biogenesis.","volume":"19","author":"Cao","year":"2024","journal-title":"Biol Direct"},{"key":"R4-20260218","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbrc.2021.02.063","article-title":"Precision hyperthermia-induced miRNA-409-3p upregulation inhibits migration, invasion, and EMT of gastric cancer cells by targeting KLF17.","volume":"549","author":"Feng","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"R5-20260218","first-page":"748","article-title":"Serum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients.","volume":"89","author":"Cuellar-Gomez","year":"2021","journal-title":"Cir Cir"},{"key":"R6-20260218","first-page":"396","article-title":"miRNA-381-3p functions as a tumor suppressor to inhibit gastric cancer by targeting fibroblast growth factor receptor-2.","volume":"38","author":"Gao","year":"2023","journal-title":"Cancer Biother Radiopharm"},{"key":"R7-20260218","doi-asserted-by":"crossref","first-page":"1163977","DOI":"10.3389\/fmolb.2023.1163977","article-title":"Comprehensive analysis to construct a novel immune-related prognostic panel in aging-related gastric cancer based on the lncRNA\u2013miRNA-mRNA ceRNA network.","volume":"10","author":"Deng","year":"2023","journal-title":"Front Mol Biosci"},{"key":"R8-20260218","first-page":"2346","article-title":"The lung cancer associated MicroRNAs and single nucleotides polymorphisms: a mendelian randomization analysis.","volume":"2020","author":"Huang","year":"2020","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"R9-20260218","first-page":"388","article-title":"The lncRNA-miRNA-integrin alpha V ceRNA network can affect the occurrence and prognosis of gastric cancer.","volume":"15","author":"Chen","year":"2022","journal-title":"Int J Clin Exp Pathol"},{"key":"R10-20260218","doi-asserted-by":"crossref","first-page":"779455","DOI":"10.3389\/fgene.2021.779455","article-title":"Identifying potential mirna biomarkers for gastric cancer diagnosis using machine learning variable selection approach.","volume":"12","author":"Gilani","year":"2021","journal-title":"Front Genet"},{"key":"R11-20260218","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1038\/ncomms7601","article-title":"Genome-wide identification of microRNA expression quantitative trait loci.","volume":"6","author":"Huan","year":"2015","journal-title":"Nat Commun"},{"key":"R12-20260218","doi-asserted-by":"crossref","first-page":"185","DOI":"10.32604\/or.2024.042281","article-title":"lncRNA SNHG4 enhanced gastric cancer progression by modulating miR-409-3p\/CREB1 axis.","volume":"33","author":"Cheng","year":"2025","journal-title":"Oncol Res"},{"key":"R13-20260218","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2012.02.030","article-title":"MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer.","volume":"320","author":"Li","year":"2012","journal-title":"Cancer Lett"},{"key":"R14-20260218","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1007\/s10620-020-06816-z","article-title":"Plasma exosomal CircNEK9 accelerates the progression of gastric cancer via miR-409-3p\/MAP7 axis.","volume":"66","author":"Yu","year":"2021","journal-title":"Dig Dis Sci"},{"key":"R15-20260218","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/onc.2011.581","article-title":"MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.","volume":"31","author":"Zheng","year":"2012","journal-title":"Oncogene"},{"key":"R16-20260218","first-page":"10383","article-title":"MiR-127-3p inhibits proliferation of ovarian cancer in rats through down-regulating MAPK4.","volume":"24","author":"Du","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R17-20260218","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/1873-3468.13624","article-title":"Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5.","volume":"594","author":"Fan","year":"2020","journal-title":"FEBS Lett"},{"key":"R18-20260218","first-page":"630","article-title":"MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.","volume":"23","author":"Ji","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R19-20260218","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.pan.2023.10.019","article-title":"Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma.","volume":"23","author":"Harada","year":"2023","journal-title":"Pancreatology"},{"key":"R20-20260218","doi-asserted-by":"crossref","first-page":"4649890","DOI":"10.1155\/2021\/4649890","article-title":"miR-370-3p as a novel biomarker promotes breast cancer progression by targeting FBLN5.","volume":"2021","author":"Mao","year":"2021","journal-title":"Stem Cells Int"},{"key":"R21-20260218","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mce.2019.02.020","article-title":"CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas.","volume":"488","author":"Cai","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"R22-20260218","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.3390\/ijms21103610","article-title":"Mir-370-3p impairs glioblastoma stem-like cell malignancy regulating a complex interplay between HMGA2\/HIF1A and the oncogenic long non-coding RNA (lncRNA) NEAT1.","volume":"21","author":"Lulli","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R23-20260218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2018.11.012","article-title":"miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.","volume":"54","author":"Liu","year":"2019","journal-title":"Cell Signal"},{"key":"R24-20260218","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12957-022-02638-7","article-title":"miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K\/Akt signaling pathway.","volume":"20","author":"Lv","year":"2022","journal-title":"World J Surg Oncol"},{"key":"R25-20260218","first-page":"1319","article-title":"Cancer\u2011associated fibroblast\u2011derived exosomal miR\u2011382\u20115p promotes the migration and invasion of oral squamous cell carcinoma.","volume":"42","author":"Sun","year":"2019","journal-title":"Oncol Rep"},{"key":"R26-20260218","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.2147\/OTT.S196322","article-title":"The role of miR-382-5p in glioma cell proliferation, migration and invasion.","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R27-20260218","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1515\/med-2021-0369","article-title":"miR-654-5p promotes gastric cancer progression via the GPRIN1\/NF-\u03baB pathway.","volume":"16","author":"Zhou","year":"2021","journal-title":"Open Med (Wars)"},{"key":"R28-20260218","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4251\/wjgo.v12.i4.492","article-title":"Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer.","volume":"12","author":"Li","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"R29-20260218","doi-asserted-by":"crossref","first-page":"4914707","DOI":"10.1155\/2020\/4914707","article-title":"miR-654-5p Targets HAX-1 to regulate the malignancy behaviors of colorectal cancer cells.","volume":"2020","author":"Huang","year":"2020","journal-title":"Biomed Res Int"},{"key":"R30-20260218","doi-asserted-by":"crossref","first-page":"8225966","DOI":"10.1155\/2022\/8225966","article-title":"The clinical value of blood miR-654-5p, miR-126, miR-10b, and miR-144 in the diagnosis of colorectal cancer.","volume":"2022","author":"Du","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"R31-20260218","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dna.2017.4095","article-title":"miR-654-5p targets GRAP to promote proliferation, metastasis, and chemoresistance of oral squamous cell carcinoma through Ras\/MAPK signaling.","volume":"37","author":"Lu","year":"2018","journal-title":"DNA Cell Biol"},{"key":"R32-20260218","doi-asserted-by":"crossref","first-page":"590447","DOI":"10.3389\/fimmu.2021.590447","article-title":"Targeting miR-148b-5p inhibits immunity microenvironment and gastric cancer progression.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"R33-20260218","doi-asserted-by":"crossref","first-page":"101601","DOI":"10.1016\/j.mcp.2020.101601","article-title":"MiR-34a suppresses the proliferation and invasion of gastric cancer by modulating PDL1 in the immune microenvironment.","volume":"53","author":"Yong","year":"2020","journal-title":"Mol Cell Probes"},{"key":"R34-20260218","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.3934\/mbe.2020219","article-title":"Integrative analysis of immune microenvironment-related CeRNA regulatory axis in gastric cancer.","volume":"17","author":"Chen","year":"2020","journal-title":"Math Biosci Eng"},{"key":"R35-20260218","first-page":"1560307","article-title":"N-trans-feruloyloctopamine wakes up BBC3, DDIT3, CDKN1A, and NOXA signals to accelerate HCC cell apoptosis.","volume":"2021","author":"Ma","year":"2021","journal-title":"Anal Cell Pathol (Amst)"},{"key":"R36-20260218","doi-asserted-by":"crossref","first-page":"117005","DOI":"10.1016\/j.taap.2024.117005","article-title":"Zinc finger protein 367 exerts a cancer-promoting role in small cell lung cancer by influencing the CIT\/LATS2\/YAP signaling cascade.","volume":"489","author":"Kong","year":"2024","journal-title":"Toxicol Appl Pharmacol"},{"key":"R37-20260218","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13023-023-02705-6","article-title":"Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis.","volume":"18","author":"Wang","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"R38-20260218","doi-asserted-by":"crossref","first-page":"908943","DOI":"10.3389\/fonc.2022.908943","article-title":"The role of SETBP1 in gastric cancer: friend or foe.","volume":"12","author":"Fang","year":"2022","journal-title":"Front Oncol"},{"key":"R39-20260218","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.2147\/OTT.S176511","article-title":"Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer.","volume":"11","author":"Chen","year":"2018","journal-title":"Onco Targets Ther"},{"key":"R40-20260218","doi-asserted-by":"crossref","first-page":"861655","DOI":"10.3389\/fimmu.2022.861655","article-title":"Analysis of a miR-148a targetome in B cell central tolerance.","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"key":"R41-20260218","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/nar\/gkad1142","article-title":"The miRNA-target interactions: an underestimated intricacy.","volume":"52","author":"Diener","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"R42-20260218","doi-asserted-by":"crossref","first-page":"189366","DOI":"10.1016\/j.bbcan.2025.189366","article-title":"miRNA expression based modulation: a new paradigm for the treatment of chronic myeloid leukemia.","volume":"1880","author":"Ansari","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R43-20260218","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.tibs.2021.01.007","article-title":"Extracellular miRNAs and cell-cell communication: problems and prospects.","volume":"46","author":"Makarova","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"R44-20260218","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.gastro.2021.12.252","article-title":"Stem cells, helicobacter pylori, and mutational landscape: utility of preclinical models to understand carcinogenesis and to direct management of gastric cancer.","volume":"162","author":"Liabeuf","year":"2022","journal-title":"Gastroenterology"},{"key":"R45-20260218","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13059-024-03420-6","article-title":"A comprehensive study of genetic regulation and disease associations of plasma circulatory microRNAs using population-level data.","volume":"25","author":"Mustafa","year":"2024","journal-title":"Genome Biol"},{"key":"R46-20260218","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40364-024-00626-5","article-title":"Dysregulation of plasma circulating microRNAs in all-cause and cause-specific cancers: the rotterdam study.","volume":"12","author":"Shuai","year":"2024","journal-title":"Biomark Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:02:51Z","timestamp":1771434171000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046833","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"2025-08-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}